Cullinan Therapeutics Statistics

Total Valuation

CGEM has a market cap or net worth of $447.63 million. The enterprise value is $145.34 million.

Market Cap	447.63M
Enterprise Value	145.34M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025, before market open.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

CGEM has 59.01 million shares outstanding. The number of shares has increased by 37.06% in one year.

Current Share Class	59.01M
Shares Outstanding	59.01M
Shares Change (YoY)	+37.06%
Shares Change (QoQ)	+0.55%
Owned by Insiders (%)	3.99%
Owned by Institutions (%)	81.40%
Float	39.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.81
P/TBV Ratio	0.81
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.62, with a Debt / Equity ratio of 0.00.

Current Ratio	11.62
Quick Ratio	11.11
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.57% and return on invested capital (ROIC) is -26.58%.

Return on Equity (ROE)	-36.57%
Return on Assets (ROA)	-25.38%
Return on Invested Capital (ROIC)	-26.58%
Return on Capital Employed (ROCE)	-37.83%
Revenue Per Employee	n/a
Profits Per Employee	-$1.61M
Employee Count	111
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, CGEM has paid $117,000 in taxes.

Income Tax	117,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -56.48% in the last 52 weeks. The beta is -0.04, so CGEM's price volatility has been lower than the market average.

Beta (5Y)	-0.04
52-Week Price Change	-56.48%
50-Day Moving Average	8.14
200-Day Moving Average	11.44
Relative Strength Index (RSI)	37.31
Average Volume (20 Days)	348,530

Short Selling Information

The latest short interest is 6.18 million, so 10.47% of the outstanding shares have been sold short.

Short Interest	6.18M
Short Previous Month	5.99M
Short % of Shares Out	10.47%
Short % of Float	15.85%
Short Ratio (days to cover)	13.84

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-208.93M
Pretax Income	-156.28M
Net Income	-178.74M
EBITDA	-208.62M
EBIT	-208.93M
Earnings Per Share (EPS)	-$3.10

Full Income Statement

Balance Sheet

The company has $303.83 million in cash and $1.84 million in debt, giving a net cash position of $301.99 million or $5.12 per share.

Cash & Cash Equivalents	303.83M
Total Debt	1.84M
Net Cash	301.99M
Net Cash Per Share	$5.12
Equity (Book Value)	551.84M
Book Value Per Share	9.40
Working Capital	290.42M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-150.21M
Capital Expenditures	n/a
Free Cash Flow	-150.21M
FCF Per Share	-$2.55

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CGEM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-37.06%
Shareholder Yield	-37.06%
Earnings Yield	-39.96%
FCF Yield	-33.58%

Analyst Forecast

The average price target for CGEM is $30.00, which is 295.52% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.00
Price Target Difference	295.52%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	2.48%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1